Multiple Genetic Mutations Associated with Polymyxin Resistance in Acinetobacter baumannii

Area of Science:

• Microbiology
• Genetics
• Infectious Diseases

Background:

• Polymyxin B is a critical antibiotic for treating multidrug-resistant Gram-negative bacteria.
• Acinetobacter baumannii is a significant nosocomial pathogen known for developing antibiotic resistance.
• Mechanisms of polymyxin B resistance are not fully understood, particularly differences between in vivo and in vitro acquisition.

Purpose of the Study:

• To investigate the genetic basis and phenotypic characteristics of polymyxin B resistance in clinical Acinetobacter baumannii isolates.
• To compare polymyxin B resistance mechanisms acquired in vivo versus in vitro.
• To identify key genes and mutations associated with resistance development.

Main Methods:

• Comparative analysis of 10 paired clinical Acinetobacter baumannii isolates (parent and resistant strains).
• Phenotypic characterization including growth rate assessment and antibiotic susceptibility testing.
• Genotypic analysis focusing on mutations in lpx and pmrB genes.

Main Results:

• All polymyxin B-resistant isolates exhibited reduced growth rates compared to their susceptible parent strains.
• Substitution mutations in the lpx or pmrB genes were identified in resistant isolates.
• Significant differences in antibiotic susceptibility profiles and genetic resistance determinants were observed between in vivo and in vitro acquired polymyxin B resistance.

Conclusions:

• In vivo development of polymyxin B resistance in Acinetobacter baumannii is associated with specific gene mutations and altered growth rates.
• Distinct genetic pathways and phenotypic consequences differentiate in vivo from in vitro polymyxin B resistance acquisition.
• Understanding these differences is crucial for effective treatment strategies against resistant Acinetobacter baumannii infections.